Yangxinshi Tablets Versus Trimetazidine on Exercise Tolerance After Percutaneous Coronary Intervention: Rationale and Design of the Double-blind, Randomized HEARTRIP Trial

Yangxinshi Tablets Versus Trimetazidine on Exercise Tolerance After Percutaneous Coronary Intervention: Rationale and Design of the Double-blind, Randomized HEARTRIP Trial

Improving exercise tolerance is indisputably beneficial for long-term survival in patients treated with percutaneous coronary intervention (PCI). Although previous studies suggested that Yangxinshi tablets effectively improve exercise tolerance in patients with coronary heart disease, the evidence i...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yi Li, Jian Zhang, Hong Chen, Yi Zhang, Jing Li, Haichu Yu, Xiaoping Meng, Haitao Yuan, Lili Shao, Yaling Han
Format:	Article
Language:	English
Published:	Wolters Kluwer Health/LWW 2023-06-01
Series:	Cardiology Discovery
Online Access:	http://journals.lww.com/10.1097/CD9.0000000000000094
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RATIONALE FOR APPLICATION, AND BENEFITS OF TRIMETAZIDINE IN HEART FAILURE BY ITS INFLUENCE OF MYOCARDIUM METABOLISM
by: Yu. M. Lopatin, et al.
Published: (2016-08-01)

Assessment of Trimetazidine Treatment in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention
by: Xiuying Tang, et al.
Published: (2022-01-01)

Effects of Trimetazidine Pretreatment on Endothelial Dysfunction and Myocardial Injury in Unstable Angina Patients Undergoing Percutaneous Coronary Intervention
by: Shuai Shao, et al.
Published: (2019-01-01)

AN EXPERIENCE OF TRIMETAZIDINE USAGE IN COMORBIDITY
by: I. V. Kochetkova, et al.
Published: (2018-04-01)

ISCHEMIC SYNDROMES AND CYTOPROTECTION (TRIMETAZIDINE)
by: A. A. Gorbachenkov, et al.
Published: (2001-10-01)

CYTOPROTECTION WITH TRIMETAZIDINE MB: RECENT DATA
by: I. G. Gordeev, et al.
Published: (2015-05-01)

Effectiveness and Tolerability of Trimetazidine 80 mg Once Daily in Patients with Chronic Coronary Syndrome in Brazil: The V-GOOD Observational Study
by: Luís Henrique Wolff Gowdak, et al.
Published: (2025-04-01)

Synergistic interaction between trimetazidine and ketoprophen in mice
by: Daniela Carmen Ababei, et al.
Published: (2015-06-01)

Efficacy of Trimetazidine and Sulodexide in Patients with Microvascular Angina
by: S. A. Boldueva, et al.
Published: (2020-07-01)

THE USAGE OF TRIMETAZIDINE IN COMPLEX TREATMENT OF HEART FAILURE
by: N. R. Paleev, et al.
Published: (2001-04-01)

Effectiveness of the original trimetazidine MR in patients with stable coronary heart disease and angina attacks resistant to trimetazidine generics (ETALON study)
by: A. V. Fendrikova, et al.
Published: (2011-08-01)

Trimetazidine MB treatment in patients with chronic heart failure
by: T. E. Morozova, et al.
Published: (2010-06-01)

Cardioprotective Effect of Trimetazidine in Cardiac Contusion: Experimental Study
by: O. V. Korpacheva, et al.
Published: (2008-04-01)

ADDITIONAL USE OF TRIMETAZIDINE IN PATIENTS WITH CHRONIC HEART FAILURE. A META-ANALYSIS
by: Lei Zhang, et al.
Published: (2015-12-01)

Formulation Optimization and Quality Analysis of Dendrobium officinale Chewable Tablets
by: Wenyu ZHANG, et al.
Published: (2025-02-01)

Comparison of penetrating needles and non-penetrating needles with electrical stimulation combined with exercise training for relieving dyspnea and improving exercise tolerance in chronic obstructive pulmonary disease patients: A single-blind randomized controlled trial
by: Ying He, et al.
Published: (2025-03-01)

ANTIISCHEMIC METABOLIC MODULATOR TRIMETAZIDINE IN TREATMENT OF CORONARY HEART DISEASE
by: V. P. Lupanov
Published: (2017-02-01)

THE STUDY ON TOLERABILITY AND EFFICACY OF THE NEW COMPLEX DRUG HELMINTAL TABLETS BASED ON MOXIDECTIN AND PRAZIQUANTEL
by: M. V. Arisov, et al.
Published: (2016-12-01)

Adaptive Blind Stokes-Space Based Equalizer for RSOP in SV-DD Systems With High Chromatic Dispersion Tolerance
by: Yu Jin, et al.
Published: (2020-01-01)

Rationale and protocol for a safety, tolerability and feasibility randomized, parallel arm, double-blind, placebo-controlled, pilot study of a novel ketone ester targeting frailty via immunometabolic geroscience mechanisms.
by: Brianna J Stubbs, et al.
Published: (2024-01-01)

Prognostic Analysis and an Appropriate Antiplatelet Strategy for Patients With Percutaneous Coronary Intervention and High Bleeding Risk: Rationale and Protocol for a Multi-Center Cohort Study
by: Junyan Zhang, et al.
Published: (2024-09-01)

EFFECTS OF TRIMETAZIDINE ON THE TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: Yu. N. Fedulaev, et al.
Published: (2015-09-01)

MEMBRANE-SАVING ACTION OF TRIMETAZIDINE IN SUBJECTS WITH ACUTE MYOCARDIAL INFARCTION
by: S. V. Vasilyev, et al.
Published: (2014-12-01)

TRIMETAZIDINE AND MILDRONATE AS DIRECT ACTION Β2 - ADRENOSENSIBILIZERS (EXPERIMENTAL EVIDENCE)
by: V. I. Tsirkin, et al.
Published: (2002-02-01)

Effects of trimetazidine on oxidant-antioxidant balance and angiogenesis; an in vivo experimental study
by: Fethullah Kayan, et al.
Published: (2025-04-01)

Trimetazidine in chronic heart failure patients aged above 75 years
by: I. V. Ignatenko, et al.
Published: (1970-01-01)

Rationale and design of Low-Frequency REpetitive TRanscranial Magnetic Stimulation Combined with Endovascular Treatment in ACute Ischaemic StrokE (RETRACE II): a randomised double-blind controlled multicentre phase II pilot study
by: Yongjun Wang, et al.

Trimetazidine MR effects on heart remodeling in stable coronary heart disease patients
by: E. M. Khurs, et al.
Published: (2007-02-01)

Trimetazidine in coronary heart disease patients: mechanism of action and controlled trials’ results
by: L. V. Kremneva, et al.
Published: (2005-04-01)

Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study.
by: Laurent Cotte, et al.
Published: (2017-01-01)

Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial
by: Cyrus Cooper, et al.
Published: (2013-12-01)

Effect of fitting tolerance on mechanical performance of CFRP/Al double-lap blind riveted joints
by: Hanli Zhang, et al.
Published: (2025-07-01)

Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis
by: Gabriel C. Barsotti, et al.
Published: (2024-05-01)

Combination of trimetazidine and coenzyme Q10 for the treatment of acute viral myocarditis: a systematic review and meta-analysis
by: Min Zeng, et al.
Published: (2024-05-01)

Study of the effect of food on the bioavailability, safety and tolerability of Aterixen<sup>®</sup> 100 mg tablet in healthy volunteers
by: V. B. Vasilyuk, et al.
Published: (2023-07-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

TRIMETAZIDINE THERAPY INFLUENCE ON HEART RATE VARIABILITY IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
by: M. V. Novikova, et al.
Published: (2014-10-01)

The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use
by: O. V. Tsygankova, et al.
Published: (2019-12-01)

Trimetazidine stimulates intracellular Ca2+ transients and zebrafish locomotor activity in spinal neurons
by: Sara Bernardi, et al.
Published: (2025-07-01)

MANAGEMENT OF ANGINA ATTACKS IN HEART FAILURE DUE TO NONCORONARY HEART DISEASE: TRIMETAZIDINE USAGE
by: M. Yu. Sitnikova, et al.
Published: (2015-11-01)